Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing Klebsiella pneumoniae (KAPEDIS).
Elena Pérez-NadalesÁngela CanoManuel RecioMaría José ArtachoJulia Guzmán-PucheAntonio DoblasElisa VidalClara NateraLuis Martínez-MartínezJulian Torre-CisnerosJuan José CastónPublished in: BMJ open (2022)
NCT04760665.
Keyphrases
- klebsiella pneumoniae
- placebo controlled
- double blind
- phase iii
- study protocol
- clinical trial
- phase ii
- multidrug resistant
- escherichia coli
- end stage renal disease
- randomized controlled trial
- open label
- newly diagnosed
- prognostic factors
- chronic kidney disease
- systematic review
- acinetobacter baumannii
- phase ii study
- gram negative
- stem cells
- drug resistant
- radiation therapy
- pseudomonas aeruginosa
- cell therapy
- bone marrow
- mesenchymal stem cells
- patient reported